scholarly journals Serum proteomics reveals disorder of lipoprotein metabolism in sepsis

2021 ◽  
Vol 4 (10) ◽  
pp. e202101091
Author(s):  
Xi Liang ◽  
Tianzhou Wu ◽  
Qi Chen ◽  
Jing Jiang ◽  
Yongpo Jiang ◽  
...  

Sepsis is defined as an organ dysfunction syndrome and it has high mortality worldwide. This study analysed the proteome of serum from patients with sepsis to characterize the pathological mechanism and pathways involved in sepsis. A total of 59 patients with sepsis were enrolled for quantitative proteomic analysis. Weighted gene co-expression network analysis (WGCNA) was performed to construct a co-expression network specific to sepsis. Key regulatory modules that were detected were highly correlated with sepsis patients and related to multiple functional groups, including plasma lipoprotein particle remodeling, inflammatory response, and wound healing. Complement activation was significantly associated with sepsis-associated encephalopathy. Triglyceride/cholesterol homeostasis was found to be related to sepsis-associated acute kidney injury. Twelve hub proteins were identified, which might be predictive biomarkers of sepsis. External validation of the hub proteins showed their significantly differential expression in sepsis patients. This study identified that plasma lipoprotein processes played a crucial role in sepsis patients, that complement activation contributed to sepsis-associated encephalopathy, and that triglyceride/cholesterol homeostasis was associated with sepsis-associated acute kidney injury.

2021 ◽  
Vol 118 (37) ◽  
pp. e2104347118
Author(s):  
Ravi Shankar Keshari ◽  
Narcis Ioan Popescu ◽  
Robert Silasi ◽  
Girija Regmi ◽  
Cristina Lupu ◽  
...  

Late-stage anthrax infections are characterized by dysregulated immune responses and hematogenous spread of Bacillus anthracis, leading to extreme bacteremia, sepsis, multiple organ failure, and, ultimately, death. Despite the bacterium being nonhemolytic, some fulminant anthrax patients develop a secondary atypical hemolytic uremic syndrome (aHUS) through unknown mechanisms. We recapitulated the pathology in baboons challenged with cell wall peptidoglycan (PGN), a polymeric, pathogen-associated molecular pattern responsible for the hemostatic dysregulation in anthrax sepsis. Similar to aHUS anthrax patients, PGN induces an initial hematocrit elevation followed by progressive hemolytic anemia and associated renal failure. Etiologically, PGN induces erythrolysis through direct excessive activation of all three complement pathways. Blunting terminal complement activation with a C5 neutralizing peptide prevented the progressive deposition of membrane attack complexes on red blood cells (RBC) and subsequent intravascular hemolysis, heme cytotoxicity, and acute kidney injury. Importantly, C5 neutralization did not prevent immune recognition of PGN and shifted the systemic inflammatory responses, consistent with improved survival in sepsis. Whereas PGN-induced hemostatic dysregulation was unchanged, C5 inhibition augmented fibrinolysis and improved the thromboischemic resolution. Overall, our study identifies PGN-driven complement activation as the pathologic mechanism underlying hemolytic anemia in anthrax and likely other gram-positive infections in which PGN is abundantly represented. Neutralization of terminal complement reactions reduces the hemolytic uremic pathology induced by PGN and could alleviate heme cytotoxicity and its associated kidney failure in gram-positive infections.


2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Alessandra Stasi ◽  
ROSSANA FRANZIN ◽  
Fabio Sallustio ◽  
Chiara Divella ◽  
Claudia Curci ◽  
...  

Abstract Background and Aims Sepsis-induced acute kidney injury (AKI) is a growing health care problem, refractory to conventional treatments. This disease is characterized by an overwhelmed immune response against a primary insult that become responsible for renal dysfunction and poor outcome. Therapeutic strategies based on blood purification have been developed for the treatment of this disease. The use of polymethyl methacrylate (PMMA) membrane hemofilter in continuous hemodiafiltration (CHDF) modality showed better hemodynamic stability and efficient renal support in chronic dialysis maintenance. Here we investigated the efficacy of Hemofeel PMMA membrane (TORAY, Japan) in interfering with Complement activation and renal damage in a swine model of sepsis-induced AKI. Method After 3 hours from LPS infusion, 7 hours of PMMA-CVVH treatment or 7 hours of polysulfone (PSF)-CVVH were performed. Animals were sacrificed after 24h from LPS infusion. Histologic and renal function parameters were analyzed in all pigs. Pentraxin-3 (PTX3) and C5b-9 deposits were assessed on renal biopsies. Systemic Complement activation was evaluated by Wieslab kit. Gene expression profile was obtained from isolated PBMCs by Agilent SurePrint G3 Porcine Gene Expression Microarrays. Genespring and R software were used for the analysis. Results were validated by Real-time PCR. Results Analysis of renal biopsies from septic pigs presented increased interstitial leucocyte infiltrate, extensive collagen deposition and diffuse glomerular thrombi compared to healthy pigs (p<0.05). Confocal analysis showed extensive PTX-3 and C5-b9 deposits at tubulo-interstitial level associated with significant activation of systemic complement classical and alternative pathways (p<0.05). Interestingly, PMMA-CVVH treatment significantly reduced local and systemic complement activation, leucocyte infiltrate and tubule-interstitial fibrosis (p<0.05). On the contrary, no significant improvement was observed by PSF-CVVH treatment. Then, we compared the whole-genome gene expression profiles of swine PBMC. We identified 711 differentially expressed genes comparing PBMC before LPS infusion (LPS T0) and after 24 hours from LPS infusion (LPS T24) and 913 genes comparing gene expression profiles of LPS T24 group with that of septic pigs treated with PMMA-CVVH (PMMA T24 group) (fold change >2 ; false discovery rate <0.05). The most modulated genes were Granzime B, Complement Factor B, Complement Component 4 Binding Protein Alpha, IL-12, SERPINB-1 and TIMP-2 that were closely related to sepsis-induced immunological process. Finally, quantitative PCR confirmed the microarray data indicating that Granzime B and Complement Factor B upregulation in PBMC was significantly hampered by PMMA treatment. Conclusion Our data suggest that LPS induced AKI is characterized by activation of Classical and alternative Complement pathways resulting in significant renal tissue damage. By interfering with complement activation and inflammatory response, PMMA membrane might prevent dysfunctional activation of resident renal cells with prevention of sepsis-induced AKI.


2019 ◽  
Vol 12 (9) ◽  
pp. e228709 ◽  
Author(s):  
Hatem Elabd ◽  
Mennallah Elkholi ◽  
Lewis Steinberg ◽  
Anjali Acharya

The kidney is one of the major organs affected in preeclampsia. There is evidence suggesting a role for excessive complement activation in the pathogenesis of preeclampsia. We describe a case of preeclampsia with severe features, including HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) and acute kidney injury (AKI) that developed following caesarian section. The patient required renal replacement therapy. A trial of daily plasma exchange was not effective. The patient received a single dose of eculizumab, a humanised monoclonal IgG antibody that binds to complement protein C5. One week post administration of eculizumab, there was significant improvement in haematologic, hepatic and renal function. Blood pressure had normalised and renal replacement therapy was discontinued. The use of eculizumab may have contributed to recovery of kidney function further supporting the role of complement activation in the pathogenesis of preeclampsia and associated AKI.


2020 ◽  
Author(s):  
Liwei Liu ◽  
Jin Liu ◽  
Li Lei ◽  
Bo Wang ◽  
Guoli Sun ◽  
...  

Abstract Background: Risk stratification is recommended as the key step to prevent contrast-associated acute kidney injury (CA-AKI) by allowing for prevention among at-risk patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). Patients with hypoalbuminemia are prone to CA-AKI and do not have their own risk stratification tool. Therefore, we developed and validated a model for predicting CA-AKI in patients with hypoalbuminemia undergoing CAG/PCI.Methods: A total of 1272 consecutive patients with hypoalbuminemia undergoing CAG/PCI were enrolled and randomly assigned (2:1 ratio) to a development cohort (n = 848) and a validation cohort (n = 424). CA-AKI was defined as a serum creatinine (SCr) increase of ≥ 0.3 mg/dL or 50% from baseline within the first 48 to 72 hours following CAG/PCI. A prediction model was established with independent predictors according to multivariate logistic regression and a stepwise approach, showing as a nomogram. The discrimination of the nomogram was assessed by the area under the receiver operating characteristic (ROC) curve and was compared to the classic Mehran CA-AKI score. Calibration was assessed using the Hosmer–Lemeshow test.Results: Overall, 8.4% (71/848) of patients in the development cohort and 11.2% (48/424) of patients in the validation cohort experienced CA-AKI. The simple nomogram included estimated glomerular filtration rate (eGFR), serum albumin (ALB), age and the use of intra-aortic balloon pump (IABP); showed better predictive ability than the Mehran score (C-index 0.756 vs. 0.693, p = 0.02); and had good calibration (Hosmer–Lemeshow test p = 0.187). Conclusions: Our data suggested that the simple model might be a good tool for predicting CA-AKI in high-risk patients with hypoalbuminemia undergoing CAG/PCI, but our findings require further external validation.Trial registration number NCT01400295


2021 ◽  
Vol 4 (8) ◽  
pp. e2121901
Author(s):  
Todd A. Wilson ◽  
Lawrence de Koning ◽  
Robert R. Quinn ◽  
Kelly B. Zarnke ◽  
Eric McArthur ◽  
...  

2020 ◽  
Vol 3 (8) ◽  
pp. e2012892 ◽  
Author(s):  
Matthew M. Churpek ◽  
Kyle A. Carey ◽  
Dana P. Edelson ◽  
Tripti Singh ◽  
Brad C. Astor ◽  
...  

2020 ◽  
Vol 13 (3) ◽  
pp. 402-412
Author(s):  
Samira Bell ◽  
Matthew T James ◽  
Chris K T Farmer ◽  
Zhi Tan ◽  
Nicosha de Souza ◽  
...  

Abstract Background Improving recognition of patients at increased risk of acute kidney injury (AKI) in the community may facilitate earlier detection and implementation of proactive prevention measures that mitigate the impact of AKI. The aim of this study was to develop and externally validate a practical risk score to predict the risk of AKI in either hospital or community settings using routinely collected data. Methods Routinely collected linked datasets from Tayside, Scotland, were used to develop the risk score and datasets from Kent in the UK and Alberta in Canada were used to externally validate it. AKI was defined using the Kidney Disease: Improving Global Outcomes serum creatinine–based criteria. Multivariable logistic regression analysis was performed with occurrence of AKI within 1 year as the dependent variable. Model performance was determined by assessing discrimination (C-statistic) and calibration. Results The risk score was developed in 273 450 patients from the Tayside region of Scotland and externally validated into two populations: 218 091 individuals from Kent, UK and 1 173 607 individuals from Alberta, Canada. Four variables were independent predictors for AKI by logistic regression: older age, lower baseline estimated glomerular filtration rate, diabetes and heart failure. A risk score including these four variables had good predictive performance, with a C-statistic of 0.80 [95% confidence interval (CI) 0.80–0.81] in the development cohort and 0.71 (95% CI 0.70–0.72) in the Kent, UK external validation cohort and 0.76 (95% CI 0.75–0.76) in the Canadian validation cohort. Conclusion We have devised and externally validated a simple risk score from routinely collected data that can aid both primary and secondary care physicians in identifying patients at high risk of AKI.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Iacopo Vagliano ◽  
Nicholas Chesnaye ◽  
Jan Hendrik Leopold ◽  
Kitty J Jager ◽  
Ameen Abu Hanna ◽  
...  

Abstract Background and Aims Acute kidney injury (AKI) has a substantial impact on global disease burden of Chronic Kidney Disease. To assist physicians with the timely diagnosis of AKI, several prognostic models have been developed to improve early recognition across various patient populations with varying degrees of predictive performance. In the prediction of AKI, machine learning (ML) techniques have been demonstrated to improve on the predictive ability of existing models that rely on more conventional statistical methods. ML is a broad term which refers to various types of models: Parametric models, such as linear or logistic regression use a pre-specified model form which is believed to fit the data, and its parameters are estimated. Non-parametric models, such as decision trees, random forests, and neural networks may have varying complexity (e.g. the depth of a classification tree model) based on the data. Deep learning neural network models exploit temporal or spatial arrangements in the data to deal with complex predictors. Given the rapid growth and development of ML methods and models for AKI prediction over the past years, in this systematic review, we aim to appraise the current state-of-the-art regarding ML models for the prediction of AKI. To this end, we focus on model performance, model development methods, model evaluation, and methodological limitations. Method We searched the PubMed and ArXiv digital libraries, and selected studies that develop or validate an AKI-related multivariable ML prediction model. We extracted data using a data extraction form based on the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) and CHARMS (critical appraisal and data extraction for systematic reviews of prediction modelling studies) checklists. Results Overall, 2,875 titles were screened and thirty-four studies were included. Of those, thirteen studies focussed on intensive care, for which the US derived MIMIC dataset was commonly used; thirty-one studies both developed and validated a model; twenty-one studies used single-centre data. Non-parametric ML methods were used more often than regression and deep learning. Random forests was the most popular method, and often performed best in model comparisons. Deep learning was typically used (and also effective) when complex features were included (e.g., with text or time series). Internal validation was often applied, and the performance of ML models was usually compared against logistic regression. However, the simple training/test split was often used, which does not account for the variability of the training and test samples. Calibration, external validation, and interpretability of results were rarely considered. Comparisons of model performance against medical scores or clinicians were also rare. Reproducibility was limited, as data and code were usually unavailable. Conclusion There is an increasing number of ML models for AKI, which are mostly developed in the intensive care environment largely due to the availability of the MIMIC dataset. Most studies are single-centre, and lack a prospective design. More complex models based on deep learning are emerging, with the potential to improve predictions for complex data, such as time-series, but with the disadvantage of being less interpretable. Future studies should pay attention to using calibration measures, external validation, and on improving model interpretability, in order to improve uptake in clinical practice. Finally, sharing data and code could improve reproducibility of study findings.


Sign in / Sign up

Export Citation Format

Share Document